CRY1
CRY1[edit | edit source]
CRY1 (Cryptochrome Circadian Regulator 1) is a protein that plays a crucial role in the regulation of the circadian rhythms in humans and other organisms. It is encoded by the CRY1 gene located on chromosome 12 in humans. Cryptochromes are a class of flavoproteins that are sensitive to blue light and are involved in the entrainment of the circadian clock to the light-dark cycle.
Structure[edit | edit source]
CRY1 is a member of the cryptochrome family, which also includes CRY2. The protein structure of CRY1 includes a photolyase homology region (PHR) that binds flavin adenine dinucleotide (FAD) and a C-terminal extension that is involved in protein-protein interactions. The PHR domain is responsible for the light-sensing properties of cryptochromes.
Function[edit | edit source]
CRY1 is a core component of the circadian clock, which is an internal time-keeping system that regulates various physiological processes in a roughly 24-hour cycle. CRY1, along with PER (Period) proteins, forms a complex that inhibits the activity of the CLOCK-BMAL1 transcription factor complex. This negative feedback loop is essential for the generation and maintenance of circadian rhythms.
CRY1 also plays a role in the regulation of various biological processes, including sleep-wake cycles, hormone release, and metabolism. It is involved in the modulation of gene expression in response to environmental light cues.
Genetic Variants[edit | edit source]
Mutations and polymorphisms in the CRY1 gene have been associated with alterations in circadian rhythms. For example, certain variants of CRY1 have been linked to delayed sleep phase disorder (DSPD), a condition characterized by a delay in the sleep-wake cycle.
Clinical Significance[edit | edit source]
Understanding the function and regulation of CRY1 is important for the development of treatments for circadian rhythm disorders. Research into CRY1 and its interactions with other circadian clock components may provide insights into the mechanisms underlying sleep disorders, metabolic diseases, and mood disorders.
Research[edit | edit source]
Ongoing research is focused on elucidating the precise molecular mechanisms by which CRY1 influences circadian rhythms and how it interacts with other clock proteins. Studies are also exploring the potential therapeutic applications of targeting CRY1 in the treatment of circadian-related disorders.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD